Germany's hypnotic and sedative medicine sales per capita are forecasted to remain stable at $1.3 from 2024 to 2028. In 2023, the value was also $1.3 per capita, indicating no growth or decline as there is a 0% year-on-year variation in the period from 2023 to 2028. This stability suggests market saturation or a static demand-supply scenario.
Future trends to watch for include potential shifts in healthcare policies affecting prescription practices, the impact of new sleep disorder treatments entering the market, changes in public perception and stigmatization of hypnotics and sedatives, and the growing interest in non-pharmacological treatments such as digital therapeutics.
